col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
AME Publishing Company: Journal of Laboratory and Precision Medicine
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―17 Vitamin D status during the COVID-19 pandemic: a pragmatic approach to measurement and supplementation Giuseppe Lippi, Camilla Mattiuzzi
2 [GO] 2023―Oct―30 Impact of COVID-19 pandemic on serum 25-hydroxyvitamin D levels in Brazilian patients Gabriel Pissolati M. Bretz, João Rodrigo Campos, Adriano Alonso Veloso, Karina Braga Gomes, Adriano Basques Fernandes
3 [GO] 2023―Oct―30 Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine Laura Pighi, Brandon M. Henry, Gian Luca Salvagno, Giuseppe Lippi
4 [GO] 2023―Jul―28 COVID-19: the global health emergency is over for the WHO, but not yet for laboratory medicine Giuseppe Lippi, Mario Plebani
5 [GO] 2023―Jan―05 Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections Eloísa Urrechaga, Pedro Pablo España, Ane Uranga, Mónica Fernández, Rana Zeeshan Haider, Luis Garcia de Guadiana, Urko Aguirre
6 [GO] 2023―Jan―04 Nationwide analysis of COVID-19 death rate throughout the pandemic in Italy Camilla Mattiuzzi, Giuseppe Lippi
7 [GO] 2022―Oct―26 COVID-19 diagnostics and early phase clinical trials: challenges and risk mitigation in the Omicron variants era Brandon Michael Henry, Giuseppe Lippi
8 [GO] 2022―Aug―29 Comparison of SARS-CoV-2 anti-spike IgG and anti-nucleoprotein IgG seroprevalence amongst a pre-vaccine cohort of healthcare workers at an academic medical center in Boston, Massachusetts Manisha Cole, Maura C. Dodge, Elizabeth R. Duffy, Jordyn N. Osterland, Susan H. Gawel, Lei Ye, et al. (+8)
9 [GO] 2022―Jul―19 COVID-19 vaccination in patients taking immunosuppressant drugs: what is the best strategy for improving immunogenicity? Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry
10 [GO] 2022―Jun―16 Is cellular immunity the future key for deciphering and monitoring COVID-19 vaccines efficacy? Giuseppe Lippi, Camilla Mattiuzzi, Brandon M. Henry
11 [GO] 2022―Mar―31 The landscape of SARS-CoV-2 genomic mutations Giuseppe Lippi, Brandon M. Henry
12 [GO] 2021―Sep―01 Specific leukocyte differential and morphological alarms a clue for the detection of SARS-CoV-2 infection Eloísa Urrechaga, Oihane Bóveda, Milagros Hernández, Blanca García San Vicente, Mónica Fernández, Helena Redín, et al. (+4)
13 [GO] 2021―Jun―16 Comparing the performance of two commercial assays for detection of SARS-CoV-2 in samples with low viral load Kok-Siong Poon, Nancy Wen-Sim Tee
14 [GO] 2021―May―13 Emerging COVID-19 diagnostics in context-what about testing saliva? Kok-Siong Poon, Nancy Wen-Sim Tee
15 [GO] 2021―May―13 Potential drawbacks of pharmacy-based COVID-19 testing Giuseppe Lippi, Brandon Michael Henry, Mario Plebani
16 [GO] 2021―Jan―31 Altered lipid profile in patients with COVID-19 infection Vincenzo Roccaforte, Massimo Daves, Giuseppe Lippi, Marta Spreafico, Claudio Bonato
17 [GO] 2021―Jan―31 The real origin of SARS-CoV-2: does it really matter? Giuseppe Lippi, Brandon M. Henry, Fabian Sanchis-Gomar
18 [GO] 2020―Oct―22 Assessment of immune response against SARS-CoV-2 at emergency department evaluation in COVID-19 patients Justin L. Benoit, Stefanie W. Benoit, James Rose, Jonathan Hoehn, Giuseppe Lippi, Brandon Michael Henry
19 [GO] 2020―Oct―22 Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi Steven Munharo, Symon Nayupe, Patrick Mbulaje, Parth Patel, Confidence Banda, Kristine Joy Abordo Gacutno, et al. (+3)
 [1] 

19 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec